IMPACTING CUTTING-EDGE RESEARCH
Solving complex problems takes looking at issues in new and different ways. We are honored to be associated with the growing base of cutting edge research our grants have supported. Each researcher is making a valuable contribution to the fight against breast cancer. Examples of the doctors and types of research our work has helped to support include:
JENNIFER PIETENPOL, PhD |
HEATHER CUNLIFFE, PhD |
BRYAN SCHNEIDER, PhD |
From the first grant to much larger initiatives...
We have learned through conversations with researchers that impacting meaningful research can be accomplished in many ways. Whether it is taking steps to support a younger researcher looking for their first grant or being a part of a much larger research initiative led by a highly established team, each piece of work plays an important role in the overall fight. Exemplary research which we have helped to support includes but is not limited to:
Triple Negative Breast Cancer: Subtypes, Molecular Targets and Therapeutic Approaches
Jennifer Pietenpol, PhD
A Susan G. Komen grant, supported in part by the Milburn Foundation
Marker Discovery and Validation in a Prospectively Collected IBC Cohort
John Martens, Ph.D
Erasmus Universitair Medisch Centrum Rotterdam
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Function of Lymphatic Vessels in Rapid Progression of Inflammatory Breast Cancer
Mihaela Skobe, Ph.D
The Icahn School of Medicine at Mount Sinai
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Translational Genomics (TGen): Molecular Characterization of TNIBC
Heather Cunliffe, PhD
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Underlying Molecular Underpinning of Inflammatory Breast Cancer using Next Generation Sequencing
Bryan Schneider, PhD and Milan Racovich, PhD
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Identifying Potential Therapeutic Targets in Inflammatory Breast Cancer Following Neoadjuvant Chemotherapy
Dr. Robert J. Schneider
NYU Medical Center
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Validation of Jak2 as Novel Therapeutic Target in Triple Negative Inflammatory Breast Cancer
Dr. Beth Overmoyer
Dana Farber Cancer Institute
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Translating mTOR and Translational Regulation to Therapy in Triple Negative Inflammatory Breast Cancer
Robert J. Schneider, PhD
NYU Medical Center
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Development of Mouse Models of Inflammatory Breast Cancer Brain Metastasis
Diane Palmieri, PhD.
National Cancer Institure
An IBC Research Foundation grant, supported in part by the Milburn Foundation
We have learned through conversations with researchers that impacting meaningful research can be accomplished in many ways. Whether it is taking steps to support a younger researcher looking for their first grant or being a part of a much larger research initiative led by a highly established team, each piece of work plays an important role in the overall fight. Exemplary research which we have helped to support includes but is not limited to:
Triple Negative Breast Cancer: Subtypes, Molecular Targets and Therapeutic Approaches
Jennifer Pietenpol, PhD
A Susan G. Komen grant, supported in part by the Milburn Foundation
Marker Discovery and Validation in a Prospectively Collected IBC Cohort
John Martens, Ph.D
Erasmus Universitair Medisch Centrum Rotterdam
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Function of Lymphatic Vessels in Rapid Progression of Inflammatory Breast Cancer
Mihaela Skobe, Ph.D
The Icahn School of Medicine at Mount Sinai
A Susan G. Komen grant, supported by the Milburn Foundation and IBC Research Foundation
Translational Genomics (TGen): Molecular Characterization of TNIBC
Heather Cunliffe, PhD
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Underlying Molecular Underpinning of Inflammatory Breast Cancer using Next Generation Sequencing
Bryan Schneider, PhD and Milan Racovich, PhD
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Identifying Potential Therapeutic Targets in Inflammatory Breast Cancer Following Neoadjuvant Chemotherapy
Dr. Robert J. Schneider
NYU Medical Center
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Validation of Jak2 as Novel Therapeutic Target in Triple Negative Inflammatory Breast Cancer
Dr. Beth Overmoyer
Dana Farber Cancer Institute
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Translating mTOR and Translational Regulation to Therapy in Triple Negative Inflammatory Breast Cancer
Robert J. Schneider, PhD
NYU Medical Center
An IBC Research Foundation grant, supported in part by the Milburn Foundation
Development of Mouse Models of Inflammatory Breast Cancer Brain Metastasis
Diane Palmieri, PhD.
National Cancer Institure
An IBC Research Foundation grant, supported in part by the Milburn Foundation
